title: Polymorphisms of POR, SULT2A1 and HSD11B1 in children with premature adrenarche.
abstract: Premature adrenarche (PA) refers to an earlier than normal increase in adrenocortical androgen production. The pathogenesis of PA remains largely unknown. We hypothesized that common polymorphisms at P450 oxidoreductase (POR), steroid sulfotransferase (SULT2A1), or 11β-hydroxysteroid dehydrogenase type 1 (HSD11B1) genes could contribute to the polygenic pathogenesis of PA. We performed a case-control study on the polymorphisms rs1057868 at POR, rs182420 at SULT2A1, and rs12086634 at HSD11B1. The study cohort comprised 73 prepubertal children with PA (defined by clinical signs) and 97 age- and gender-matched healthy controls from a Finnish Caucasian population. Genotype distributions and clinical and metabolic phenotypes were determined. The genotype distributions of the polymorphisms were similar between the study groups. No variant was associated with alterations in serum adrenal steroid concentrations. The minor C variant at SULT2A1 was associated with higher serum sex hormone binding globulin (SHBG) concentrations (T/T, n=64 vs T/C&C/C, n=33; mean 94 vs 116 nmol/L; P=.001) and a trend for lower dehydroepiandrosterone sulfate/dehydroepiandrosterone ratios in the controls (P=.06), and with higher plasma total cholesterol concentrations in the PA subjects (T/T, n=42 vs T/C&C/C, n=31; 4.0 vs 4.6 mmol/L; P<.001). The minor G variant at HSD11B1 was associated with lower plasma triglyceride concentration in the controls (T/T, n=65 vs T/G&G/G, n=32; 0.61 vs 0.49 mmol/L; P=.013). Common polymorphisms at POR, SULT2A1 or HSD11B1 were not associated with PA in a Finnish Caucasian population.
authors.affiliation: Department of Pediatrics, Kuopio University Hospital and University of Eastern Finland P.O. Box 1777, FI-70211 Kuopio, Finland. pauliina.utriainen@uef.fi
authors.forename: Pauliina
authors.initials: P
authors.lastname: Utriainen
authors.forename: Saila
authors.initials: S
authors.lastname: Laakso
authors.forename: Jarmo
authors.initials: J
authors.lastname: Jääskeläinen
authors.forename: Raimo
authors.initials: R
authors.lastname: Voutilainen
mesh_terms: D043205:11-beta-Hydroxysteroid Dehydrogenase Type 1 / Q000235:genetics; D000293:Adolescent; D050499:Adrenarche / Q000097:blood / Q000235:genetics* / Q000378:metabolism; D015415:Biomarkers / Q000097:blood; D016022:Case-Control Studies; D002648:Child; D002675:Child, Preschool; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism*; D003579:Cytochrome Reductases / Q000235:genetics*; D005260:Female; D005387:Finland / Q000453:epidemiology; D005838:Genotype; D006801:Humans; D008297:Male; D020641:Polymorphism, Single Nucleotide; D012738:Sex Hormone-Binding Globulin / Q000378:metabolism; D015238:Sulfotransferases / Q000235:genetics*; D044465:White People / Q000235:genetics*
chemical_list: D015415:Biomarkers; D012738:Sex Hormone-Binding Globulin; D003577:Cytochrome P-450 Enzyme System; D043205:11-beta-Hydroxysteroid Dehydrogenase Type 1; C468386:HSD11B1 protein, human; D003579:Cytochrome Reductases; D015238:Sulfotransferases; C028152:alcohol sulfotransferase